Article Details
Retrieved on: 2024-04-27 14:42:15
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses an epidemiological study on dose-sparing mpox vaccination regimens sponsored by NIAID and conducted during the mpox outbreak, showcasing their effectiveness and safety. The study's relevance aligns with vaccines, notably the Modified vaccinia Ankara vaccine used by Bavarian Nordic, in response to global health concerns.
Article found on: www.eurekalert.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here